Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 179

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis

Open access
Romano, B, Borrelli, F, Fasolino, I, Capasso, R, Piscitelli, F, Cascio, MG, Pertwee, RG, Coppola, D, Vassallo, L, Orlando, P, Di Marzo, V, Izzo, AA·2013·British Journal of Pharmacology

Abstract

Background and Purpose: The non‐psychotropic cannabinoid cannabichromene is known to activate the transient receptor potential ankyrin‐type1 (TRPA1) and to inhibit endocannabinoid inactivation, both of which are involved in inflammatory processes. We examined here the effects of this phytocannabinoid on peritoneal macrophages and its efficacy in an experimental model of colitis. Experimental Approach: Murine peritoneal macrophages were activated in vitro by LPS. Nitrite levels were measured using a fluorescent assay; inducible nitric oxide (iNOS), cyclooxygenase‐2 (COX‐2) and cannabinoid (CB 1 and CB 2) receptors were analysed by RT‐PCR (and/or W estern blot analysis); colitis was induced by dinitrobenzene sulphonic acid (DNBS). Endocannabinoid (anandamide and 2‐arachidonoylglycerol), palmitoylethanolamide and oleoylethanolamide levels were measured by liquid chromatography‐mass spectrometry. Colonic inflammation was assessed by evaluating the myeloperoxidase activity as well as by histology and immunohistochemistry. Key Results: LPS caused a significant production of nitrites, associated to up‐regulation of anandamide, iNOS, COX‐2, CB 1 receptors and down‐regulation of CB 2 receptors mRNA expression. Cannabichromene significantly reduced LPS‐stimulated nitrite levels, and its effect was mimicked by cannabinoid receptor and TRPA1 agonists (carvacrol and cinnamaldehyde) and enhanced by CB 1 receptor antagonists. LPS‐induced anandamide, iNOS, COX‐2 and cannabinoid receptor changes were not significantly modified by cannabichromene, which, however, increased oleoylethanolamide levels. I n vivo, cannabichromene ameliorated DNBS‐induced colonic inflammation, as revealed by histology, immunohistochemistry and myeloperoxidase activity. Conclusion and Implications: Cannabichromene exerts anti‐inflammatory actions in activated macrophages – with tonic CB 1 cannabinoid signalling being negatively coupled to this effect – and ameliorates experimental murine colitis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.12120

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 179

Metadata

Authors
Romano, B., Borrelli, F., Fasolino, I., Capasso, R., Piscitelli, F., Cascio, M., Pertwee, R., Coppola, D., Vassallo, L., Orlando, P., Di Marzo, V, & Izzo, A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2013-04-12
Volume
169
Issue
1
Pages
213-229
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1553123291
Cited by
179
References
6
FWCI
8.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. https://app.cochat.ai/papers/10.1111/bph.12120
The paper
Romano, B., Borrelli, F., Fasolino, I., Capasso, R., Piscitelli, F., Cascio, M., Pertwee, R., Coppola, D., Vassallo, L., Orlando, P., Di Marzo, V, & Izzo, A. (2013). The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. British Journal of Pharmacology. https://doi.org/10.1111/bph.12120

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.